Vir Biotechnology (VIR) Restructuring Costs (2023 - 2025)

Vir Biotechnology has reported Restructuring Costs for 3 years, with the latest figure at -$172000.0 in Q2 2025.

• Quarterly Restructuring Costs fell 100.65% year-over-year to -$172000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$172000.0 (down 100.49% YoY) and the FY2025 annual result came in at -$182000.0, down 100.52% from the prior year.
• Restructuring Costs slipped to -$172000.0 in Q2 2025 per VIR's latest filing, from -$10000.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $26.3 million in Q2 2024 and troughed at -$3.9 million in Q4 2024.
• A 3-year average of $5.4 million and a median of $3.4 million in 2023 frame the typical range for Restructuring Costs.
• The widest YoY moves for Restructuring Costs: up 389.66% in 2024, down 181.81% in 2024.
• Over 3 years, Restructuring Costs stood at $4.8 million in 2023, then sank by 181.81% to -$3.9 million in 2024, then soared by 95.64% to -$172000.0 in 2025.
• According to Business Quant data, Restructuring Costs over the past three periods registered -$172000.0, -$10000.0, and -$3.9 million for Q2 2025, Q1 2025, and Q4 2024 respectively.